Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (111-120 of 578) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|August 1, 2018
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot studyIgnace Vergote, Roger von Moos, Luis Manso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 28, 2011
Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical studyIngrid Vandenput, An Capoen, Lieve Coenegrachts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancerIgnace Vergote, Claes G Tropé, Frédéric Amant, et al.
Acta Obstetricia Et Gynecologica Scandinavica|April 18, 2013
Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinomaMaxime Fastrez, Frédéric Goffin, Ignace Vergote, et al.
Gynecologic and Obstetric Investigation|March 23, 2017
Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?Sien Delattre, Sileny Han, Philippe Moerman, et al.
Gynecologic Oncology|August 22, 2006
Transition of endometrial stromal sarcoma into high-grade sarcomaFrederic Amant, Heidi Woestenborghs, Vanessa Vandenbroucke, et al.
Gynecologic Oncology|July 30, 2005
CD10, estrogen and progesterone receptor expression in ovarian adenosarcomaTim Van Mieghem, Vera M Abeler, Philippe Moerman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 25, 2013
The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancerRaj Naik, Nick Spirtos, Christophe Pomel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2018
Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary SurgeryTina Laga, Sandrina Lambrechts, Annouschka Laenen, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Dendritic cell immunotherapy in uterine cancerAn Coosemans, Sandra Tuyaerts, Anke Vanderstraeten, et al.
Pageof 58

Showing results (111-120 of 578) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|August 1, 2018
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot studyIgnace Vergote, Roger von Moos, Luis Manso, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 28, 2011
Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical studyIngrid Vandenput, An Capoen, Lieve Coenegrachts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancerIgnace Vergote, Claes G Tropé, Frédéric Amant, et al.
Acta Obstetricia Et Gynecologica Scandinavica|April 18, 2013
Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinomaMaxime Fastrez, Frédéric Goffin, Ignace Vergote, et al.
Gynecologic and Obstetric Investigation|March 23, 2017
Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?Sien Delattre, Sileny Han, Philippe Moerman, et al.
Gynecologic Oncology|August 22, 2006
Transition of endometrial stromal sarcoma into high-grade sarcomaFrederic Amant, Heidi Woestenborghs, Vanessa Vandenbroucke, et al.
Gynecologic Oncology|July 30, 2005
CD10, estrogen and progesterone receptor expression in ovarian adenosarcomaTim Van Mieghem, Vera M Abeler, Philippe Moerman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 25, 2013
The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancerRaj Naik, Nick Spirtos, Christophe Pomel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2018
Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary SurgeryTina Laga, Sandrina Lambrechts, Annouschka Laenen, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Dendritic cell immunotherapy in uterine cancerAn Coosemans, Sandra Tuyaerts, Anke Vanderstraeten, et al.
Pageof 58